Anaprilin-Zdorovye 40mg 2p x 50 tablets — Made in Ukraine — Free Delivery

Anaprilin-Zdorovye tablets are used for the following indications. Control of essential and renal hypertension, angina pectoris, long-term preventive therapy after myocardial infarction, control of most forms of cardiac arrhythmias, prevention of migraine, essential tremor, control of excitation and excitation tachycardia, additional therapy for thyrotoxicosis and thyrotoxic crisis; as part of combined therapy - pheochromocytoma (only in combination with α-adrenoblockers).

Active substance: 1 tablet contains propranolol hydrochloride 10 mg or 40 mg;

Excipients: talc, corn starch, hypromellose, colloidal silicon dioxide, calcium stearate, microcrystalline cellulose.

Hypersensitivity to the components of the preparation, cardiogenic shock, AV block II and III degree, sinoatrial block, sinus node weakness syndrome, sinus bradycardia (heart rate less than 50 bpm), Prinzmetal's angina, arterial hypotension, uncontrolled heart failure, bronchial asthma or bronchospasm in the anamnesis, severe disorders of peripheral blood circulation, metabolic acidosis (including diabetic acidosis), after prolonged fasting, untreated pheochromocytoma, diabetes mellitus, chronic liver diseases.

Administer inside 10-30 minutes before meals, drinking a sufficient amount of liquid. The dosage regimen is individual. The dose and duration of treatment is determined by the doctor.

pregnant

Use during pregnancy is impossible except when the expected benefit for the pregnant woman exceeds the potential risk for the fetus.

Children

The preparation should be prescribed to children aged 3 years and older.

Drivers

With caution.

Symptoms: dizziness, pronounced arterial hypotension, bradycardia, arrhythmia, heart failure, collapse, acrocyanosis, convulsions, difficulty breathing, bronchospasm.

Treatment: gastric lavage, appointment of adsorbents.

The preparation is usually well tolerated, but the following side effects may occur.

From the side of the heart: arterial hypotension, orthostatic hypotension, sinus bradycardia, blockade, development / progression of heart failure, impaired peripheral blood circulation.

From the blood side: thrombocytopenia, thrombocytopenic purpura, leukopenia, agranulocytosis.

From the nervous system: asthenia, dizziness, headache, insomnia or drowsiness, nightmares, decreased speed of mental and motor reactions, depression, restlessness, confusion or short-term amnesia, paresthesias, hallucinations, seizures, psychosis, mood changes.

On the part of the organ of vision: impaired visual acuity, decreased secretion of tear fluid, dryness and soreness of the eyes, keratoconjunctivitis.

From the respiratory system: pharyngitis, cough, shortness of breath, respiratory distress syndrome, bronchospasm and laryngospasm.

From the side of the digestive system: nausea, vomiting, pain in the epigastric area, diarrhea or constipation, thrombosis of the mesenchymal artery, ischemic colitis.

From the side of the skin and subcutaneous tissue: skin reactions, itching, rashes, alopecia, exacerbation of psoriasis, psoriasis-like skin reactions.

From the endocrine system: hypoglycemia.

From the vascular side: cooling of the extremities, exacerbation of intermittent lameness, Raynaud's syndrome.

From the side of the digestive system: impaired liver function (including cholestasis).

Propranolol reverses the tachycardia of hypoglycemia. Patients with diabetes should be cautious with the simultaneous use of propranolol and hypoglycemic agents. Propranolol may prolong the hypoglycemic response to insulin.

Antiarrhythmic preparations of the class and amiodarone can increase the effect of propranolol on atrial conduction time and cause a negative inotropic effect.

Propranolol should be used with extreme caution in patients receiving concomitant treatment with cardiodepressants (chloroform, ether, or family anesthetics), antiarrhythmic preparations (quinidine, lidocaine, procainamide), which exacerbate depressant effects.

Guanethidine, reserpine, diuretics and other antihypertensive preparations, including preparations from the group of vasodilators, can increase the hypotensive effect of propranolol.

Store in the original packaging at a temperature not higher than 25 °C.

Keep out of the reach of children.

Shelf life - 4 years.